---
document_datetime: 2023-09-21 21:00:11
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lacosamide-ucb-epar-all-authorised-presentations_en.pdf
document_name: lacosamide-ucb-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 3.8991667
conversion_datetime: 2025-12-14 14:27:23.193741
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/19/1383/001   | Lacosamide UCB   | 10 mg/ml   | Solution for                   | Intravenous use   | vial (glass)           | 20 ml   | 1 vial                                                               |
|--------------------|------------------|------------|--------------------------------|-------------------|------------------------|---------|----------------------------------------------------------------------|
| EU/1/19/1383/002   | Lacosamide UCB   | 10 mg/ml   | infusion Solution for infusion | Intravenous use   | vial (glass)           | 20 ml   | 5 vials                                                              |
| EU/1/19/1383/003   | Lacosamide UCB   | 10 mg/ml   | Syrup                          | Oral use          | bottle (glass)         | 200 ml  | 1 bottle + 1 measuring cup 30 mL + 1 oral syringe of 10 mL + adaptor |
| EU/1/19/1383/004   | Lacosamide UCB   | 50 mg      | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 14 tablets                                                           |
| EU/1/19/1383/005   | Lacosamide UCB   | 50 mg      | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 14 x 1 tablets (unit dose)                                           |
| EU/1/19/1383/006   | Lacosamide UCB   | 50 mg      | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 28 tablets                                                           |
| EU/1/19/1383/007   | Lacosamide UCB   | 50 mg      | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 56 tablets                                                           |
| EU/1/19/1383/008   | Lacosamide UCB   | 50 mg      | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 56 x 1 tablets (unit dose)                                           |
| EU/1/19/1383/009   | Lacosamide UCB   | 50 mg      | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 168 tablets                                                          |
| EU/1/19/1383/010   | Lacosamide UCB   | 100 mg     | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 14 tablets                                                           |
| EU/1/19/1383/011   | Lacosamide UCB   | 100 mg     | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 14 x 1 tablets (unit dose)                                           |
| EU/1/19/1383/012   | Lacosamide UCB   | 100 mg     | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 28 tablets                                                           |
| EU/1/19/1383/013   | Lacosamide UCB   | 100 mg     | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 56 tablets                                                           |
| EU/1/19/1383/014   | Lacosamide UCB   | 100 mg     | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 56 x 1 tablets (unit dose)                                           |
| EU/1/19/1383/015   | Lacosamide UCB   | 100 mg     | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 168 tablets                                                          |
| EU/1/19/1383/016   | Lacosamide UCB   | 150 mg     | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 14 tablets                                                           |
| EU/1/19/1383/017   | Lacosamide UCB   | 150 mg     | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 14 x 1 tablets (unit dose)                                           |
| EU/1/19/1383/018   | Lacosamide UCB   | 150 mg     | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 28 tablets                                                           |
| EU/1/19/1383/019   | Lacosamide UCB   | 150 mg     | Film-coated tablet             | Oral use          | blister (PVC/PVDC/alu) |         | 56 tablets                                                           |

<div style=\"page-break-after: always\"></div>

## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

|                  | name           |                        | Form               | Administration   | Packaging              |                                            |
|------------------|----------------|------------------------|--------------------|------------------|------------------------|--------------------------------------------|
| EU/1/19/1383/020 | Lacosamide UCB | 150 mg                 | Film-coated tablet | Oral use         | blister (PVC/PVDC/alu) | 56 x 1 tablets (unit dose)                 |
| EU/1/19/1383/021 | Lacosamide UCB | 150 mg                 | Film-coated tablet | Oral use         | blister (PVC/PVDC/alu) | 168 (3 x 56) tablets (multipack)           |
| EU/1/19/1383/022 | Lacosamide UCB | 200 mg                 | Film-coated tablet | Oral use         | blister (PVC/PVDC/alu) | 14 tablets                                 |
| EU/1/19/1383/023 | Lacosamide UCB | 200 mg                 | Film-coated tablet | Oral use         | blister (PVC/PVDC/alu) | 14 x 1 tablets (unit dose)                 |
| EU/1/19/1383/024 | Lacosamide UCB | 200 mg                 | Film-coated tablet | Oral use         | blister (PVC/PVDC/alu) | 28 tablets                                 |
| EU/1/19/1383/025 | Lacosamide UCB | 200 mg                 | Film-coated tablet | Oral use         | blister (PVC/PVDC/alu) | 56 tablets                                 |
| EU/1/19/1383/026 | Lacosamide UCB | 200 mg                 | Film-coated tablet | Oral use         | blister (PVC/PVDC/alu) | 56 x 1 tablets (unit dose)                 |
| EU/1/19/1383/027 | Lacosamide UCB | 200 mg                 | Film-coated tablet | Oral use         | blister (PVC/PVDC/alu) | 168 (3 x 56) tablets (multipack)           |
| EU/1/19/1383/028 | Lacosamide UCB | 50 / 100/ 150 / 200 mg | Film-coated tablet | Oral use         | blister (PVC/PVDC/alu) | Treatment initiation pack: 14 tablets + 14 |
|                  |                |                        |                    |                  |                        | tablets + 14                               |
|                  |                |                        |                    |                  |                        | tablets + 14                               |
|                  |                |                        |                    |                  |                        | tablets                                    |